These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
47 related items for PubMed ID: 15191375
1. Different clinicopathological courses of two recipients of kidneys retrieved from the same non-heart beating donor. Nishikido M, Noguchi M, Koga S, Kanetake H, Harada T, Taguchi T, Watanabe J, Matsuya F, Hayashi M. Clin Transplant; 2004; 18 Suppl 11():54-60. PubMed ID: 15191375 [Abstract] [Full Text] [Related]
2. Progressive interstitial fibrosis of kidney allograft early after transplantation from a non-heart beating donor: possible role of persistent ischemic injury. Masutani K, Kitada H, Yamada S, Tsuchimoto A, Noguchi H, Tsuruya K, Katafuchi R, Tanaka M, Iida M. Clin Transplant; 2010 Jul; 24 Suppl 22():70-4. PubMed ID: 20590699 [Abstract] [Full Text] [Related]
3. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T. Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [Abstract] [Full Text] [Related]
4. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation. Matsuo N, Yamamoto H, Kobayashi A, Yamamoto I, Mitome J, Maruyama Y, Hayakawa H, Miyazaki Y, Utsunomiya Y, Hosoya T, Yamaguchi Y. Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591 [Abstract] [Full Text] [Related]
5. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation. Miura M, Ogawa Y, Kubota KC, Harada H, Shimoda N, Seki T, Hirano T, Nonomura K. Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589 [Abstract] [Full Text] [Related]
8. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression. Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC. Clin Transplant; 2008 Aug; 22(3):309-15. PubMed ID: 18482051 [Abstract] [Full Text] [Related]
9. Does MICA influence acute rejection in kidney transplantation? Kato M, Kinukawa T, Hattori R, Tsuji Y, Hirano A, Horie K, Tsuyuki M, Mizutani K. Clin Transpl; 2006 Aug; ():389-93. PubMed ID: 18365394 [Abstract] [Full Text] [Related]
10. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L. Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [Abstract] [Full Text] [Related]
11. Subclinical peritubular capillaritis in serial graft biopsies in cadaveric kidney transplant recipient with pre-transplant anti-HLA antibodies. Masutani K, Kitada H, Noguchi H, Tsuruya K, Katafuchi R, Tanaka M, Iida M. Clin Transplant; 2009 Aug; 23 Suppl 20():34-8. PubMed ID: 19594594 [Abstract] [Full Text] [Related]
12. Risk factors among donor characteristics which affect graft outcome in paired kidney transplantation. Tian YF, Liao CH, Chen MJ. Transplant Proc; 2008 Sep; 40(7):2281-4. PubMed ID: 18790212 [Abstract] [Full Text] [Related]
13. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group. Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398 [Abstract] [Full Text] [Related]
14. Steroid avoidance immunosuppression in low-risk kidney transplant recipients. Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D. Transplant Proc; 2005 May 15; 37(4):1785-8. PubMed ID: 15919466 [Abstract] [Full Text] [Related]
15. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Laftavi MR, Stephan R, Stefanick B, Kohli R, Dagher F, Applegate M, O'Keefe J, Pierce D, Rubino A, Guzowski H, Leca N, Dayton M, Pankewycz O. Surgery; 2005 Mar 15; 137(3):364-71. PubMed ID: 15746793 [Abstract] [Full Text] [Related]
16. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors. Bajjoka I, Hsaiky L, Brown K, Abouljoud M. Liver Transpl; 2008 Jan 15; 14(1):66-72. PubMed ID: 18161842 [Abstract] [Full Text] [Related]
17. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K. Ann Acad Med Stetin; 2008 Jan 15; 54(1):41-8. PubMed ID: 19127808 [Abstract] [Full Text] [Related]
18. [A case of cadaveric kidney transplantation from a heart-beating donor]. Ogihara M, Yanagida T, Chiba S, Suzuki K, Suzuki T, Yamaguchi O. Hinyokika Kiyo; 2000 Feb 15; 46(2):101-3. PubMed ID: 10769798 [Abstract] [Full Text] [Related]
19. Renal transplantation from non-heart-beating donors: a single-center 10-year experience. Alonso A, Fernández-Rivera C, Villaverde P, Oliver J, Cillero S, Lorenzo D, Valdés F. Transplant Proc; 2005 Nov 15; 37(9):3658-60. PubMed ID: 16386496 [Abstract] [Full Text] [Related]
20. Donor affected by hemosiderosis: is kidney transplantation possible? A case report. Piattoni J, Bonucchi D, Gissara Z, Baisi B, Cappelli G. Transplant Proc; 2008 Nov 15; 40(6):1827-8. PubMed ID: 18675062 [Abstract] [Full Text] [Related] Page: [Next] [New Search]